Introduction
Representatives Kathy Castor from Florida and Terri Sewell from Alabama have introduced the Affordable Premiums for Seniors Act. This legislative effort aims to undo the Trump administration’s decision to end a key Medicare subsidy program.
Purpose of the Act
The proposed act seeks to continue the Medicare Part D Premium Stabilization Demonstration through 2029. This would counter the current plan to end it after 2026, recently announced by the Centers for Medicare & Medicaid Services (CMS).
According to Castor, this move is necessary because increased prescription drug costs are hitting seniors and those with disabilities at a difficult time. “This act aims to reverse the costly decision made by the Department of Health and Human Services that could raise Medicare costs,” Castor stated.
Implications of Ending the Program
Without this subsidy, beneficiaries could face higher premiums. Nearly 25 million are enrolled in standalone Medicare Part D plans. Many retirees live on fixed incomes and already face challenges with rising expenses.
Continuing the subsidy could keep drug coverage more affordable, lawmakers argue. The Trump administration contends that the extra subsidies are no longer needed.
Functions of the Proposed Act
- Extend Medicare Part D Premium Stabilization Demonstration until 2029
- Maintain federal premium assistance for Medicare Part D plans
- Aim to lower monthly drug premiums for beneficiaries
- Reverse the decision to end the subsidy post-2026
Kevin Thompson, CEO of 9i Capital Group, highlighted that lowering premiums benefits those on fixed incomes. However, there’s a counterargument that it subsidizes insurers rather than addressing underlying drug costs.
Economic Context
The Medicare Payment Advisory Commission reported the subsidy saved seniors $312 on average in 2026. Sewell emphasized that ending the subsidy would increase financial strain for seniors dealing with climbing costs in various aspects of life.
CMS Position
CMS decided to end the demonstration after insurers gained enough operating experience. Mehmet Oz, administrator of CMS, defended the decision, citing the aim to stabilize the market without additional subsidies. Oz stated most recipients would see minor or no changes in premiums.
Michael Ryan, a financial expert, noted the program was initially a temporary measure to ease market transition. CMS argues that further subsidies could delay market stabilization.
Future Prospects
The bill faces a challenging path in a Republican-led Congress. Medicare beneficiaries are waiting for final 2027 premium data, which could influence future decisions.
Thompson acknowledged the difficulty in extending the subsidy without bipartisan support. However, the upcoming premium announcements may reveal the potential impact on Medicare costs.
Leave a Reply